Championing Cutting Edge Innovation with Robust Patent Protection: Who’s Setting the Agenda on Biologics? | McDermott

Championing Cutting Edge Innovation with Robust Patent Protection: Who’s Setting the Agenda on Biologics?

Überblick


Michael Siekman will speak on a patenting biologics panel at LSPN North America 2022 on the topic of “Championing Cutting Edge Innovation with Robust Patent Protection: Who’s setting the agenda on biologics?.”

Click here for more information and to register.